Dr. Higano on the Effectiveness of PARP Inhibitors for Prostate Cancer
Dr. Higano Discusses PARP Inhibitors in Prostate CancerПодробнее
Dr. Higano on Role of PARP Inhibitors in Prostate CancerПодробнее
Genetic Testing and Parp Inhibitors Explained | Celestial Higano, MD & Mark Moyad, MD, MPH | PCRIПодробнее
Current perspectives from clinical trials using PARP inhibitors for prostate cancerПодробнее
The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее
The Role of PARP Inhibitors in Advanced Prostate Cancer (2023)Подробнее
Dr. Morgan Discusses the Impact of PARP Inhibitors in Prostate CancerПодробнее
Dr. Morgan on the Role of PARP Inhibitors in Prostate CancerПодробнее
Which mutations benefit most from PARP inhibitors in prostate cancer?Подробнее
Choosing the correct PARP inhibitor for prostate cancerПодробнее
PARP Inhibitors for Prostate Cancer with Moshe Ornstein, MDПодробнее
The Role of PARP Inhibitors in Prostate CancerПодробнее
PARP inhibitors: their applications and efficacy against prostate cancerПодробнее
The emerging role of PARP inhibitors in prostate cancerПодробнее
Dr. Higano on the State of Immunotherapy in Prostate CancerПодробнее
Dr. Dorff Discusses the Use of PARP Inhibitors in Prostate CancerПодробнее
PARP Inhibitors in Castrate-Resistant Prostate CancerПодробнее
Celestia S. Higano, MD, on imaging as a cost-effective solution for diagnosis of prostate cancerПодробнее
Role of PARP Inhibitors in Prostate CancerПодробнее
